• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

joimax® Announces Leadership Changes, Expands U.S. Commercial Operations

June 17, 2025 By SPINEMarketGroup

KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the German-based market leader in technologies and methodologies for full-endoscopic and minimally invasive spinal surgery, announces the transition of Founder and long-standing CEO Wolfgang Ries to Executive Chairman and the appointment of Maximilian Ries to Chief Executive Officer.

After founding joimax® 24-years ago, Wolfgang Ries is stepping down as CEO to focus on research and development and to lead ESPINEA® Endoscopic Spine Academy, the only endoscopic training program accredited by the Royal College of Surgeons of Edinburgh.

Taking over as CEO is Maximilian Ries, who during his 16-year tenure at joimax®, held diverse leadership roles in product management, R&D, operations, and finance. He served as General Manager from 2016 to 2022 before returning to Germany in 2023 where he was most recently Executive Vice President of Global Operations and Business Development of joimax®.

“I am honored to lead joimax® into the next phase of growth as we continue advancing our market-leading endoscopic spine technologies,” stated Maximilian Ries. “We are seeing endoscopic spine surgery emerge as the new gold standard in minimally invasive spine care — a legacy built by Wolfgang that I’m proud to continue.”

In the lead-up to these transitions, joimax® strengthened its U.S. commercial team with several key changes, including the promotions of Anthony Troncale to President, Levon Zanadvorov, MD to Medical Director, Joe O’Connor to Vice President of U.S. Sales, Chris Lever to Vice President Business Operations and Finance, and Jarred Shewey to Director of Clinical Education, as well as the addition of Katherine Ray as Director of Global Marketing.

“I am handing off joimax® to a highly talented and experienced team of endoscopic spine experts under Max’s leadership,” said Wolfgang Ries. “I couldn’t be more excited about the company’s future and the continued advancement of endoscopic spine surgery.”

About joimax®

Founded in Karlsruhe, Germany, in 2001, joimax® is the leading developer and marketer of complete systems for full-endoscopic and minimally invasive spinal surgery. With the Endoscopic Surgical Systems TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression procedures, MultiZYTE® for facet and sacroiliac joint pain treatment, EndoLIF® and Percusys® for minimally-invasive endoscopically assisted stabilizations, established systems are provided, addressing a whole range of indications. In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax® technologies to operate through small incisions under local or full anesthesia, via tissue and muscle-sparing corridors and through natural openings in the spinal canal, e.g. the intervertebral foramen, the so-called “Kambin triangle.”

Contacts

Katherine Ray
Katherine.ray@joimaxusa.com
+1-(949)-859-3472

Related Posts:

  • joimax® Obtains Registration for All Products in the…
  • joimax® Expands Distribution in Italy – Announces…
  • joimax® Celebrates 25 Years of Advancing Endoscopic…

Filed Under: NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Is DePuy Back in the Spine Fight? Why DePuy Really…
  • Globus Medical: Stronger in Spine, but Could DePuy…
  • BROCHURES
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Highridge Medical CEO Departure: Spine’s…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • Thinking About a Spine Robot? Your 2026 Guide to the…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • Strong Surgery, Soft Quarter: ATEC and the Cost of…
  • COMPANIES
  • Autonomous Pedicle Screw Placement: Is Spine…
  • The Giant Next Door: Is Mindray Spine’s Next…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • DePuy Synthes Acquires Expanding Innovations™
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • Hospital Access Is Gone. What Comes Next for Spine…
  • VB Spine Announces VB Spine Solutions, a…
  • Top 60+ Minimally Invasive Sacroiliac Joint Fusion…
  • Sublaminar Bands in Spine Surgery: Why This Small…
  • Who Is PAULA, and Why Should Every Deformity Surgeon…
  • Johnson & Johnson Explores Potential $20B Sale…
  • Percutaneous MIS Spine Systems: Why Adoption Still…
  • What Is Medtronic’s PILAR™ Technique?
  • Orthopedics Is Moving Into Pain. Zimmer and Globus…
  • Globus Medical Reports First Quarter 2026 Results
  • L&K Spine Performs First U.S. Deformity Case…
  • ProFlex Spine: Can a Nitinol Implant Crack…
  • VB Spine Signs Master Agreement with Apolo Medica
  • LAST 5 VIDEOS PUBLISHED

    1. Mighty Oak: Acorn 3D™
    2. Syntropiq: Lyra
    3. ATEC Spine: SafeOp®
    4. REACH Medical: Expandable PLIF/TLIF Cage
    5. Expanding Innovations: X-PAC®TLIF 

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup